CJC-1295 (No DAC) + Ipamorelin Blend 10mg Lab Grade Research Peptide — ≥99% Purity

Buy CJC-1295 + Ipamorelin as one 10mg research blend from CoreVionRX: a single lyophilized vial with 5mg CJC-1295 (no DAC) and 5mg Ipamorelin, 10mg total. It combines two growth-hormone-axis research peptides and is supplied for laboratory research use only.

Buy CJC-1295 + Ipamorelin 10mg: What Each Order Includes

• One sealed glass vial of white to off-white lyophilized powder: 5mg CJC-1295 (no DAC) + 5mg Ipamorelin.
• The lot-specific COA ships with your order (HPLC purity and mass-spec identity for both peptides).
• Ships from the USA to US addresses only. Orders are processed within 24-48 hours and typically arrive within 3-5 business days after shipping.
• Shipping options: Standard ($7.99) or Priority ($14.99). Standard shipping is free on orders of $250 or more (see the shipping policy).

Looking for one component? Ipamorelin 5mg is sold on its own. CoreVionRX does not sell CJC-1295 with DAC or a blend that adds GHRP-2; the CJC-1295 + Ipamorelin research guide explains how the DAC and no-DAC compounds differ.

What Is the CJC-1295 + Ipamorelin Blend?

This blend pairs CJC-1295 without DAC, a modified analog of growth hormone-releasing hormone (GHRH 1-29), with Ipamorelin, a selective growth hormone secretagogue. CJC-1295 acts at the GHRH receptor and Ipamorelin acts at the ghrelin receptor (GHS-R1a), so researchers use the pair to compare two separate pathways of the growth hormone axis.

CJC-1295 (no DAC)

CJC-1295 without DAC, also called modified GRF (1-29), is a 29-amino-acid GHRH analog with four amino-acid substitutions that make it more resistant to enzyme breakdown than native GHRH(1-29). It does not carry DAC (Drug Affinity Complex), the albumin-binding linker in CJC-1295 with DAC, which is a different compound.

Ipamorelin

Ipamorelin is a synthetic five-residue peptide (Aib-His-D-2-Nal-D-Phe-Lys-NH2) that binds the ghrelin receptor (GHS-R1a). Published animal studies describe it as selective: in those models it released growth hormone without a matching rise in ACTH or cortisol.

What published studies examined

• GHRH-receptor signaling with modified GRF (1-29) analogs, mostly in cell and animal models
• Ghrelin-receptor (GHS-R1a) selectivity of Ipamorelin in animal models
• Growth hormone release patterns in animal models

CJC-1295 + Ipamorelin 10mg at a glance

Ipamorelin data are from PubChem (CID 9831659). The lot COA confirms both components.

For the full component table, what DAC means, COA checks, lab prep concentrations and storage, see the CJC-1295 + Ipamorelin 10mg research guide.

Quality Verification

• HPLC purity verification for both compounds
• Mass spectrometry identity confirmation
• Third-party testing for contamination and sterility
• Certificate of Analysis included with order

Reconstitution & Handling

Reconstitute the CJC-1295 + Ipamorelin blend with bacteriostatic water, adding liquid slowly down the vial wall. The combined powder dissolves into a uniform solution. Store the solution at 2-8°C and protect it from light. Prepare small aliquots to avoid repeated freeze-thaw cycles.

CJC-1295 + Ipamorelin Frequently Asked Questions

Why combine CJC-1295 with Ipamorelin?

The two peptides act on different receptors: CJC-1295 on the GHRH receptor and Ipamorelin on the ghrelin receptor. One vial lets researchers study both pathways of the growth hormone axis in the same model.

What purity is the CJC-1295 + Ipamorelin blend?

The blend is ≥99% purity for each compound, verified by HPLC. Mass spectrometry confirms the identity of both CJC-1295 and Ipamorelin. A Certificate of Analysis is included with each order.

How is the blend reconstituted?

Slowly add bacteriostatic water down the vial wall. The combined lyophilized powder dissolves into a single solution containing both 5mg CJC-1295 and 5mg Ipamorelin. Store at 2-8°C after reconstitution.

What are the key differences between CJC-1295 and Ipamorelin?

CJC-1295 (no DAC) is a GHRH analog; Ipamorelin is a ghrelin receptor agonist. They act on different parts of the growth hormone axis.

Related research peptides

• Ipamorelin 5mg (on its own)
• Tesamorelin 10mg
• MOTS-c 40mg

The CJC-1295 + Ipamorelin blend is supplied for laboratory and research use only. Not for human or animal consumption.

Sources & References:

• Raun K, et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol. 1998;139(5):552-561. Study type: rat pituitary cells, rats and swine (Novo Nordisk).
• Jetté L, et al. Human growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats: identification of CJC-1295 as a long-lasting GRF analog. Endocrinology. 2005;146(7):3052-3058. Study type: rat pituitary cells and rats. Describes CJC-1295 as tetrasubstituted hGRF(1-29) with the albumin-binding (DAC) group added.
• Teichman SL, et al. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. J Clin Endocrinol Metab. 2006;91(3):799-805. Study type: randomized, placebo-controlled human trials of CJC-1295 with DAC, a different compound from the no-DAC CJC-1295 in this blend.